PL1673391T3 - Modyfikowany cDNA do wyrażania wysokich poziomów czynnika VIII i jego pochodnych - Google Patents

Modyfikowany cDNA do wyrażania wysokich poziomów czynnika VIII i jego pochodnych

Info

Publication number
PL1673391T3
PL1673391T3 PL04790326T PL04790326T PL1673391T3 PL 1673391 T3 PL1673391 T3 PL 1673391T3 PL 04790326 T PL04790326 T PL 04790326T PL 04790326 T PL04790326 T PL 04790326T PL 1673391 T3 PL1673391 T3 PL 1673391T3
Authority
PL
Poland
Prior art keywords
derivatives
factor viii
dna sequences
expression vectors
expression levels
Prior art date
Application number
PL04790326T
Other languages
English (en)
Inventor
Hans-Peter Hauser
Jean-Luc Plantier
Cecille Ducasse
Claude Negrier
Original Assignee
Claude Negrier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claude Negrier filed Critical Claude Negrier
Publication of PL1673391T3 publication Critical patent/PL1673391T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04790326T 2003-10-16 2004-10-13 Modyfikowany cDNA do wyrażania wysokich poziomów czynnika VIII i jego pochodnych PL1673391T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03023637 2003-10-16
EP04790326A EP1673391B1 (en) 2003-10-16 2004-10-13 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
PCT/EP2004/011445 WO2005040213A1 (en) 2003-10-16 2004-10-13 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES

Publications (1)

Publication Number Publication Date
PL1673391T3 true PL1673391T3 (pl) 2009-06-30

Family

ID=34486073

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04790326T PL1673391T3 (pl) 2003-10-16 2004-10-13 Modyfikowany cDNA do wyrażania wysokich poziomów czynnika VIII i jego pochodnych

Country Status (15)

Country Link
US (1) US20080312143A1 (pl)
EP (1) EP1673391B1 (pl)
JP (1) JP4804356B2 (pl)
AT (1) ATE417066T1 (pl)
AU (1) AU2004283833A1 (pl)
BR (1) BRPI0415296A (pl)
CA (1) CA2541280A1 (pl)
DE (1) DE602004018349D1 (pl)
DK (1) DK1673391T3 (pl)
ES (1) ES2319198T3 (pl)
IL (1) IL174645A0 (pl)
PL (1) PL1673391T3 (pl)
PT (1) PT1673391E (pl)
SI (1) SI1673391T1 (pl)
WO (1) WO2005040213A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2543629T3 (es) 2006-05-17 2015-08-20 Hoffmann-La Roche Ag Células productoras de polipéptidos
FR2913020B1 (fr) 2007-02-23 2012-11-23 Biomethodes Nouveaux facteurs viii pour le traitement des hemophiles de type a
EP3452102B9 (en) 2016-04-15 2024-09-04 The Trustees of The University of Pennsylvania Gene therapy for treating hemophilia a
JP6818134B2 (ja) 2016-09-29 2021-01-20 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ポリペプチド産生細胞を選択するための改善された方法
CN109507435A (zh) * 2018-11-23 2019-03-22 重庆医科大学 Grp78蛋白双抗夹心elisa法检测试剂盒及其检测方法
GB202108855D0 (en) * 2021-06-21 2021-08-04 Cambridge Entpr Ltd Methods of eukaryotic gene expression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197321B (en) * 1986-09-12 1990-10-03 Genentech Inc Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
DK0874057T3 (da) * 1993-06-10 2004-11-22 Bayer Ag Vektor og pattedyrcellelinie med forbedret produktionsevne
EP1048726B1 (en) * 1999-04-27 2006-07-26 Négrier, Claude Modified factor VIII cDNA
EP1038959A1 (en) * 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
EP1233064A1 (en) * 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modified factor VIII cDNA and its use for the production of factor VIII
EP1283263A1 (en) * 2001-08-08 2003-02-12 Aventis Behring GmbH Modified cDNA for high expression levels of factor VIII and its derivatives
EP1284290A1 (en) * 2001-08-08 2003-02-19 Aventis Behring GmbH Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA

Also Published As

Publication number Publication date
PT1673391E (pt) 2009-03-18
EP1673391B1 (en) 2008-12-10
SI1673391T1 (sl) 2009-06-30
IL174645A0 (en) 2006-08-20
DK1673391T3 (da) 2009-04-06
AU2004283833A1 (en) 2005-05-06
EP1673391A1 (en) 2006-06-28
CA2541280A1 (en) 2005-05-06
DE602004018349D1 (de) 2009-01-22
BRPI0415296A (pt) 2006-12-26
JP4804356B2 (ja) 2011-11-02
ES2319198T3 (es) 2009-05-05
JP2007537713A (ja) 2007-12-27
WO2005040213A1 (en) 2005-05-06
ATE417066T1 (de) 2008-12-15
US20080312143A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
PL1781782T3 (pl) Zmodyfikowane polipeptydy zależne od witaminy K
WO2006128668A3 (en) Coagulation factor x polypeptides with modified activation properties
MXPA03010079A (es) Formulaciones de oxicodona de administracion una vez al dia.
SI1548032T1 (sl) KDR peptidi in cepiva, ki obsegajo le-te
NZ587105A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
DE69434447D1 (de) Für die gentherapie verwendbare plasmide
PL1675956T3 (pl) Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
NZ505063A (en) Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions
ZA200108414B (en) Akt nucleic acids, polypeptides, and uses thereof.
WO2002102316A3 (en) Histone deacetylase and methods of use thereof
IL174645A0 (en) MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
NZ334839A (en) Polynucleotide molecules encoding neospora proteins and uses thereof
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
WO2002034882A3 (en) Genes regulating programmed cell death
IL174466A0 (en) Modified cda/b7 vector
WO2002050255A3 (en) Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
AU2003296543A8 (en) Peptides having a high cysteine content
EP1221485A3 (en) Polynucleotide molecules encoding neospora proteins
WO2003095612A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2001092301A3 (en) Placc, a novel human c-c chemokine isolated from placenta
WO2003066835A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003097793A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003076577A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003076576A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003093435A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof